| Identification | Back Directory | [Name]
Lutrelin | [CAS]
66866-63-5 | [Synonyms]
Lutrelin
WY-40972
lutrelin acetate
5-Oxo-L-Pro-L-His-L-Trp-L-Ser-L-Tyr-D-Trp-N-methyl-L-Leu-L-Arg-L-Pro-ethyl-NH2
1-9-Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-7-(N-methyl-L-leucine)-9-(N-ethyl-L-prolinamide)- | [Molecular Formula]
C65H85N17O12 | [MOL File]
66866-63-5.mol | [Molecular Weight]
1296.48 |
| Hazard Information | Back Directory | [Uses]
Lutrelin (Wy 40972) is a luteinizing hormone releasing hormone (LHRH) agonist. Lutrelin inhibits the growth of the endometrial expiant in rats[1][2]. | [References]
[1] Habenicht UF, et al. Short-term effects of an LHRH-agonist alone or in combination with testosterone propionate or indomethacin on rat testes. Evidence of testosterone independent effects. I. Andrologia. 1987 Nov-Dec;19(6):602-13. DOI:10.1111/j.1439-0272.1987.tb01908.x
[2] Jones RC. The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat. Acta Endocrinol (Copenh). 1984 Jun;106(2):282-8. DOI:10.1530/acta.0.1060282 |
|
| Company Name: |
Biorbyt Ltd.
|
| Telephone: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|